OSTEOPOROSIS INTERNATIONAL

metrics 2024

Transforming Research into Clinical Practice

Introduction

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

Metrics 2024

SCIMAGO Journal Rank1.11
Journal Impact Factor4.20
Journal Impact Factor (5 years)4.30
H-Index192
Journal IF Without Self4.20
Eigen Factor0.01
Normal Eigen Factor2.90
Influence1.26
Immediacy Index0.80
Cited Half Life9.20
Citing Half Life8.00
JCI0.92
Total Documents6555
WOS Total Citations19068
SCIMAGO Total Citations79582
SCIMAGO SELF Citations7767
Scopus Journal Rank1.11
Cites / Document (2 Years)3.40
Cites / Document (3 Years)3.44
Cites / Document (4 Years)3.50

Metrics History

Rank 2024

Scopus

Endocrinology, Diabetes and Metabolism in Medicine
Rank #47/244
Percentile 80.74
Quartile Q1

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 40/186
Percentile 78.80
Quartile Q1

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 53/186
Percentile 71.51
Quartile Q2

Quartile History

Similar Journals

Bone & Joint Research

Exploring the frontiers of bone and joint health.
Publisher: BRITISH EDITORIAL SOC BONE & JOINT SURGERYISSN: 2046-3758Frequency: 12 issues/year

Bone & Joint Research is a prestigious open access journal published by the British Editorial Society of Bone & Joint Surgery, which has been serving the orthopedic and surgical community since its inception in 2012. With an impact factor reflecting its high standards and relevance within the field, this journal boasts impressive Scopus rankings, positioning it in the Q1 category for both Orthopedics and Sports Medicine and Surgery as of 2023. Located in the United Kingdom, the journal aims to disseminate cutting-edge research, clinical studies, and innovative approaches to treatment in musculoskeletal health, making it an indispensable resource for researchers, healthcare professionals, and students alike. The journal encourages a collaborative discourse that fosters advancements in the understanding and treatment of bone and joint diseases, fulfilling its mission to enhance patient outcomes and improve the quality of care.

Open Access Rheumatology-Research and Reviews

Elevating Rheumatology Research for Global Impact.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

BONE

Connecting Discoveries in Histology and Metabolism
Publisher: ELSEVIER SCIENCE INCISSN: 8756-3282Frequency: 12 issues/year

BONE, published by Elsevier Science Inc, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Endocrinology, Diabetes and Metabolism, Histology, and Physiology. Since its inception in 1985 and continuing to 2025, this journal has consistently provided high-quality research, evidenced by its impressive Q1 category rankings and strong performance in Scopus metrics—ranking #7 in Histology and achieving notable percentiles in related fields. With a commitment to advancing knowledge and understanding in bone biology and associated pathological conditions, BONE serves as an essential platform for researchers and professionals aiming to contribute to the discourse in skeletal health and disease. While it is not an open-access publication, the journal ensures a broad dissemination of pivotal research findings, making it a critical asset for academics and practitioners devoted to fostering advancements in medical sciences.

Osteoporosis and Sarcopenia

Innovating diagnostics and treatments for musculoskeletal wellness.
Publisher: ELSEVIERISSN: 2405-5255Frequency: 4 issues/year

Osteoporosis and Sarcopenia is a leading journal dedicated to the multidisciplinary exploration of diseases related to bone health and muscle degeneration, published by Elsevier. With an ISSN of 2405-5255 and an E-ISSN of 2405-5263, this open-access journal has been a vital resource since its inception in 2015, enabling unrestricted access to groundbreaking research. Its objective is to elucidate the interplay between osteoporosis and sarcopenia, offering valuable insights into diagnostics, treatment strategies, and preventive measures in the field. The journal serves as a crucial platform for researchers, healthcare professionals, and students, fostering collaboration and innovation in understanding these prevalent conditions. Given the global rise in aging populations, the significance of this journal cannot be overstated, making it an essential reference for those committed to advancing knowledge in musculoskeletal health.

Current Opinion in Endocrinology Diabetes and Obesity

Advancing Knowledge in Endocrinology, Diabetes, and Obesity
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1752-296XFrequency: 6 issues/year

Current Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.

Acta Otorrinolaringologica Espanola

Advancing knowledge in Otorhinolaryngology since 1973.
Publisher: ELSEVIER ESPANA SLUISSN: 0001-6519Frequency: 6 issues/year

Acta Otorrinolaringologica Espanola, published by Elsevier Espana SLU, is a leading journal in the field of Otorhinolaryngology, dedicated to advancing the understanding and treatment of ear, nose, and throat disorders. With a history dating back to 1973 and an established reputation for rigorously peer-reviewed research, this journal plays a pivotal role in disseminating significant findings to both clinicians and researchers. Although it is currently categorized in the Q3 quartile for 2023, ranking 72 out of 123 in its field, it serves as a vital platform for the exploration of innovative concepts and clinical practices, contributing to a deeper understanding of otolaryngological issues. While the journal is not open access, it continues to attract a wide readership due to its comprehensive articles and impactful studies. Positioned in Barcelona, Spain, this journal provides a critical resource for professionals and scholars aiming to enhance their knowledge and improve clinical outcomes in Otorhinolaryngology.

Journal of Clinical Medicine

Empowering healthcare through open access innovation.
Publisher: MDPIISSN: Frequency: 24 issues/year

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

CALCIFIED TISSUE INTERNATIONAL

Advancing knowledge on the intricacies of calcified tissues.
Publisher: SPRINGERISSN: 0171-967XFrequency: 12 issues/year

CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

Turk Osteoporoz Dergisi-Turkish Journal of Osteoporosis

Transforming osteoporosis knowledge into practice.
Publisher: GALENOS PUBL HOUSEISSN: 2147-2653Frequency: 3 issues/year

Turk Osteoporoz Dergisi - Turkish Journal of Osteoporosis, published by GALENOS PUBL HOUSE, is a vital resource for researchers and practitioners in the field of endocrinology, diabetes, and metabolism, with a specific focus on osteoporosis. Since its inception as an open-access journal in 2002, it serves to disseminate significant findings and advancements in osteoporosis research, enabling wider access to knowledge in a critical area of health that affects millions worldwide. Despite earning a Q4 categorization in 2023 within its relevant quartile ranks and being positioned at the 7th percentile among its peers in Scopus’ Endocrinology, Diabetes, and Metabolism rankings, the journal actively contributes to the dialogue on osteoporosis, covering essential topics from pathophysiology to treatment strategies. Researchers and professionals can access its contents freely, promoting collaboration and innovation in this dynamic field of study. With an ISSN of 2147-2653, this journal continues to pave the way for improved understanding and management of osteoporosis, making it a cornerstone publication for both seasoned experts and emerging scholars in Turkey and beyond.

Osteologie

Fostering Multidisciplinary Dialogue in Osteological Research
Publisher: GEORG THIEME VERLAG KGISSN: 1019-1291Frequency: 4 issues/year

Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.